<DOC>
	<DOCNO>NCT02235012</DOCNO>
	<brief_summary>Characterise cognitive bias result low dose ketamine infusion , use pharmacological model psychosis . Our assumption low dose ketamine result reason bias impair way uncertainty monitor take account decision making .</brief_summary>
	<brief_title>Cognitive Biases Under Ketamine</brief_title>
	<detailed_description>Ketamine non-competitive glutamate NMDA antagonist . The infusion subanesthetic dos ketamine result sub-clinical schizophrenia-like positive symptom healthy control . The safety ketamine use attest daily use child anesthesia number study show medical , neural cognitive complication single infusion . Low dose ketamine therefore valid safe human model study psychosis . The objective study characterise cognitive bias result low dose ketamine infusion , use pharmacological model psychosis . We design four distinct paradigm design well characterize bias . P1 neuroeconomic task subject make binary choice maximize gain , situation either direct feedback information additional counterfactual information provide . P2 neuroeconomic task direct manipulation uncertainty perform , impact decision measure . P3 perceptual decision make task , subject classify gabor orientation diagonal cardinal category base rapidly presented series individual gabor . The contribution piece evidence final decision measure correlated fluctuation eeg data . P4 perceptual decision make task , subject determine global orientation series sequentially present gabor stimulus . There interim response final response , influence former latter ( confirmation bias ) study . Our assumption low dose ketamine result reason bias impair way uncertainty monitor take account decision making . The study design follow : randomize , double blind , control , placebo , cross-over . Healthy subject therefore randomize receive first visit either ketamine infusion placebo infusion . The alternative condition apply second visit . Ketamine prepare use KETAMINE PANPHARMA 250 mg/5mL , infusion . This procedure produce ketamine plasmatic level 140ng/ml . Two blood sample take 30 90 minute infusion start record actual ketamine plasmatic level . Placebo infusion follow pattern infusion , prepare use CHLORURE DE SODIUM 0,9 % MACOPHARMA . We record behavioral , electrophysiologic psychometric data . Detailed assumption folllows : Behavioral data : P1 2 : Significant impairment ketamine ability take account uncertainty guide decision . P3 : Significant decrease ketamine ability classify correctly mean spatial orientation stimulus accord cardinal diagonal direction . P4 : Significant increase ketamine confirmation bias follow interim choice . Electroencephalographic data : Correlation impairment ability take account uncertainty alteration Error Related Negativity late inhibitory eeg signal , decrease long distance synchrony indicate spectral analysis ( P1 2 ) . The covariation brain activity weight stimuli sample final decision , increase result ketamine infusion ( P3 ) . Psychometric data : Increase Brief Psychiatric Rating Scale ( BPRS ) result ketamine infusion . The BPRS scale record psychotic symtoms translate validated french population sample .</detailed_description>
	<mesh_term>Ketamine</mesh_term>
	<criteria>Righthanded ( assessed Edinburgh scale ) Aged 18 39 Having give informed consent Health insurance Pregnant breastfeed woman ( urine pregnancy test offer doubt ) Personal firstdegree family history psychosis Personal history mood disorder , anxiety disorder , obsessivecompulsive disorder , somatoform disorder , dependence psychoactive substance , behavior disorder incompatible 2 hour EEG record . Psychotropic treatment , current stop less 1 month , include antidepressant , anxiolytic exclude hypnotic treatment . Personal history neurologic disorder relation central nervous system : congenital malformation brain , brain tumor , multiple sclerosis , degenerative disease central nervous system , epilepsy , current remission le 3 year still require medical treatment , inflammatory disease central nervous system date year result sequela . Known hypertension blood pressure 140/90 mmHg upon clinical examination , congenital heart disease , ischemic heart disease , cardiac insufficiency , supraventricular ventricular heart rhythm disorder . Person restrict liberty , result judicial administrative measure Persons involuntary commitment result psychiatric disorder . Person subject measure legal protection unable consent . Known intolerance ketamine .</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>39 Years</maximum_age>
	<verification_date>February 2016</verification_date>
	<keyword>Schizophrenia</keyword>
	<keyword>Ketamine</keyword>
	<keyword>Cognitive bias</keyword>
	<keyword>Uncertainty</keyword>
</DOC>